In addition, because technetium isotopes have short half-lives compared with the age of red giants, this finding suggested that the element was being produced within the stars, thus supporting ...

Trofolastat is a prostate-specific membrane antigen-targeting agent cleared for use with Technetium-99m for cancerous lesion detection.

Trofolastat, which was initially developed by Progenics Pharmaceuticals, is combined with Technetium-99m, a radioactive isotope widely used in diagnostic imaging, to form Technetium (99mTc ...